1. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
- Author
-
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO, and TSUTOMU MASAKI
- Subjects
Mice, Inbred BALB C ,Cancer Research ,Carcinoma, Hepatocellular ,Phenylurea Compounds ,Liver Neoplasms ,Mice, Nude ,Antineoplastic Agents ,General Medicine ,Xenograft Model Antitumor Assays ,Tumor Burden ,G2 Phase Cell Cycle Checkpoints ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Oncology ,Drug Resistance, Neoplasm ,Cell Line, Tumor ,Quinolines ,Animals ,Humans ,Female ,Cisplatin ,Protein Kinase Inhibitors ,Cell Proliferation ,Signal Transduction - Abstract
Drug resistance to molecular targeted agents, such as lenvatinib, is an important issue. The aim of this study was to explore the mechanism of lenvatinib resistance and to investigate potential drugs that may improve the treatment of lenvatinib-resistant (LR) hepatocellular carcinoma (HCC).LR cells were developed by long-term culture under lenvatinib exposure. We analyzed the biological characteristics of LR cells in vitro, and investigated the antitumor effects and endogenous mechanisms of cisplatin in LR cells.The proliferative potential of LR cells was enhanced by activation of ERK signaling and changes in several miRNAs. Cisplatin inhibited cell proliferation of LR cells and induced G2/M cell cycle arrest. Furthermore, cisplatin triggered the DNA damage response, via the ATM/ATR-Chk1/Chk2 signaling pathway.Proliferation of LR cells was induced upon ERK signaling activation. Cisplatin exerted antitumor effects in LR cells and was involved in the regulation of miRNAs associated with drug resistance.
- Published
- 2022